Cargando…

BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice

BACKGROUND: BTRX-246040, a nociceptin/orphanin FQ peptide receptor antagonist, is being developed for the treatment of depressive patients. However, the underlying mechanism of this potential antidepressant is still largely unclear. Here, we studied the antidepressant-related actions of BTRX-246040...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenlong, Xu, Yuanyuan, Li, Rourou, Sheng, Zhenyu, Chen, Xinya, Liu, Xueman, Lee, Chau-Shoun, Peng, Hsien-Yu, Lin, Tzer-Bin, Hsieh, Ming-Chun, Lai, Cheng-Yuan, Wu, Han-Fang, Chou, Dylan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388391/
https://www.ncbi.nlm.nih.gov/pubmed/37279653
http://dx.doi.org/10.1093/ijnp/pyad027
_version_ 1785082103898046464
author Li, Zhenlong
Xu, Yuanyuan
Li, Rourou
Sheng, Zhenyu
Chen, Xinya
Liu, Xueman
Lee, Chau-Shoun
Peng, Hsien-Yu
Lin, Tzer-Bin
Hsieh, Ming-Chun
Lai, Cheng-Yuan
Wu, Han-Fang
Chou, Dylan
author_facet Li, Zhenlong
Xu, Yuanyuan
Li, Rourou
Sheng, Zhenyu
Chen, Xinya
Liu, Xueman
Lee, Chau-Shoun
Peng, Hsien-Yu
Lin, Tzer-Bin
Hsieh, Ming-Chun
Lai, Cheng-Yuan
Wu, Han-Fang
Chou, Dylan
author_sort Li, Zhenlong
collection PubMed
description BACKGROUND: BTRX-246040, a nociceptin/orphanin FQ peptide receptor antagonist, is being developed for the treatment of depressive patients. However, the underlying mechanism of this potential antidepressant is still largely unclear. Here, we studied the antidepressant-related actions of BTRX-246040 in the ventrolateral periaqueductal gray (vlPAG). METHODS: The tail suspension test, forced swim test, female urine sniffing test, sucrose preference test, and learned helplessness (LH) combined with pharmacological approaches were employed to examine the antidepressant-like effects and drug effects on LH-induced depressive-like behavior in C57BL/6J mice. Electrophysiological recordings in vlPAG neurons were used to study synaptic activity. RESULTS: Intraperitoneal administration of BTRX-246040 produced antidepressant-like behavioral effects in a dose-dependent manner. Systemic BTRX-246040 (10 mg/kg) resulted in an increased frequency and amplitude of miniature excitatory postsynaptic currents (EPSCs) in the vlPAG. Moreover, slice perfusion of BTRX-246040 directly elevated the frequency and amplitude of miniature EPSCs and enhanced the evoked EPSCs in the vlPAG, which were blocked by pretreatment with the nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198. In addition, intra-vlPAG application of BTRX-246040 produced antidepressant-like behavioral effects in a dose-dependent manner. Moreover, intra-vlPAG pretreatment with 6-cyano-7-nitroquinoxaline-2,3-dione reversed both systemic and local BTRX-246040–mediated antidepressant-like behavioral effects. Furthermore, both systemic and local BTRX-246040 decreased the LH phenotype and reduced LH-induced depressive-like behavior. CONCLUSIONS: The results suggested that BTRX-246040 may act through the vlPAG to exert antidepressant-relevant actions. The present study provides new insight into a vlPAG-dependent mechanism underlying the antidepressant-like actions of BTRX-246040.
format Online
Article
Text
id pubmed-10388391
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103883912023-08-01 BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice Li, Zhenlong Xu, Yuanyuan Li, Rourou Sheng, Zhenyu Chen, Xinya Liu, Xueman Lee, Chau-Shoun Peng, Hsien-Yu Lin, Tzer-Bin Hsieh, Ming-Chun Lai, Cheng-Yuan Wu, Han-Fang Chou, Dylan Int J Neuropsychopharmacol Regular Research Articles BACKGROUND: BTRX-246040, a nociceptin/orphanin FQ peptide receptor antagonist, is being developed for the treatment of depressive patients. However, the underlying mechanism of this potential antidepressant is still largely unclear. Here, we studied the antidepressant-related actions of BTRX-246040 in the ventrolateral periaqueductal gray (vlPAG). METHODS: The tail suspension test, forced swim test, female urine sniffing test, sucrose preference test, and learned helplessness (LH) combined with pharmacological approaches were employed to examine the antidepressant-like effects and drug effects on LH-induced depressive-like behavior in C57BL/6J mice. Electrophysiological recordings in vlPAG neurons were used to study synaptic activity. RESULTS: Intraperitoneal administration of BTRX-246040 produced antidepressant-like behavioral effects in a dose-dependent manner. Systemic BTRX-246040 (10 mg/kg) resulted in an increased frequency and amplitude of miniature excitatory postsynaptic currents (EPSCs) in the vlPAG. Moreover, slice perfusion of BTRX-246040 directly elevated the frequency and amplitude of miniature EPSCs and enhanced the evoked EPSCs in the vlPAG, which were blocked by pretreatment with the nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198. In addition, intra-vlPAG application of BTRX-246040 produced antidepressant-like behavioral effects in a dose-dependent manner. Moreover, intra-vlPAG pretreatment with 6-cyano-7-nitroquinoxaline-2,3-dione reversed both systemic and local BTRX-246040–mediated antidepressant-like behavioral effects. Furthermore, both systemic and local BTRX-246040 decreased the LH phenotype and reduced LH-induced depressive-like behavior. CONCLUSIONS: The results suggested that BTRX-246040 may act through the vlPAG to exert antidepressant-relevant actions. The present study provides new insight into a vlPAG-dependent mechanism underlying the antidepressant-like actions of BTRX-246040. Oxford University Press 2023-06-05 /pmc/articles/PMC10388391/ /pubmed/37279653 http://dx.doi.org/10.1093/ijnp/pyad027 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of CINP. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular Research Articles
Li, Zhenlong
Xu, Yuanyuan
Li, Rourou
Sheng, Zhenyu
Chen, Xinya
Liu, Xueman
Lee, Chau-Shoun
Peng, Hsien-Yu
Lin, Tzer-Bin
Hsieh, Ming-Chun
Lai, Cheng-Yuan
Wu, Han-Fang
Chou, Dylan
BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice
title BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice
title_full BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice
title_fullStr BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice
title_full_unstemmed BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice
title_short BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice
title_sort btrx-246040 acts through the ventrolateral periaqueductal gray to exert antidepressant-relevant actions in mice
topic Regular Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388391/
https://www.ncbi.nlm.nih.gov/pubmed/37279653
http://dx.doi.org/10.1093/ijnp/pyad027
work_keys_str_mv AT lizhenlong btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT xuyuanyuan btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT lirourou btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT shengzhenyu btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT chenxinya btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT liuxueman btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT leechaushoun btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT penghsienyu btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT lintzerbin btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT hsiehmingchun btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT laichengyuan btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT wuhanfang btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice
AT choudylan btrx246040actsthroughtheventrolateralperiaqueductalgraytoexertantidepressantrelevantactionsinmice